WHY IS IT IMPORTANT TO USE A QUALITY MEDICAL MARIJUANA PRODUCT?
One of the most important aspects of starting a medical marijuana treatment plan is having quality products. It is always recommended that patients and clinicians only utilize products from companies that can provide Certificates of Analysis to support the claim that their products contain the marijuana compounds that are listed on the label.
With the ever-growing medical marijuana product line, patients and recommending physicians are faced with the daunting task of choosing not only the proper marijuana compound for their treatment (e.g., CBD, CBD:THC blend etc…), but also deciding what company makes the best product. This has become much more complicated with recent findings suggesting that a majority of medical marijuana products that can be purchased online are mislabeled and actually contain different ratios of cannabinoids and/or different cannabinoid compounds altogether.
In two recent studies, it was found that only 17% of edibles and 30.95% of CBD products were labeled correctly. This variability of under and over-dosed products can cause unintended and negative effects to patients.
With this, it is recommended that patients and physicians alike do their due diligence and research both the company and product. One way to ensure quality control standards is to request and review Certificates of Analysis for a product(s) that you’re interested in utilizing.
Note: All products recommended on MedicalMarijuanaEDU.com have provided Certificates of Analysis to confirm their products’ quality.
MÜV CANNABIS INFUSED PRODUCTS:
AltMed LLC and its line of MÜV marijuana infused products are focused on
bringing pharmaceutical grade precision to the medical marijuana
community. Their products are all certified by third party analysis for purity
and consistency, which is extremely important for patients and clinicians who
intend to utilize and recommend marijuana as a treatment
1. Bonn-Miller, M. O., Loflin, M. J., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R.
(2017, November 07).
2. Commissioner, O. O. (2017, November). Public Health Focus – Warning Letters and
Test Results for Cannabidiol-Related Products.
3. Raber, J. C., Raber, M. E., Douglass, B., & Miller, C. (2015, May 23). Medical
Marijuana ‘Edibles’ Mostly Mislabeled, Study Shows[Scholarly project].